Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Tulyp Medical is an Israeli medical device company dedicated to transforming the treatment of uterine fibroids through minimally invasive technology. The company has developed a proprietary, non-thermal, and non-surgical transcervical device designed to mechanically ablate fibroid tissue while preserving the integrity of the uterus. This approach offers a safer, uterus-preserving alternative to traditional surgical interventions like hysterectomy or myomectomy, significantly reducing recovery times and healthcare costs. Tulyp Medical is currently advancing its lead candidate through clinical trials to validate safety and efficacy in symptomatic women.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Tulyp Medical.